BusinessStrongbridge Biopharma plc Announces Acquisition of the U.S. and Canadian Rights to MACRILEN™ (macimorelin) from Aeterna ZentarisBy Nasdaq OMXJan 17, 2018, 12:00 PM UTC
BusinessCORRECTION -- Arzeda Strengthens Board of Directors with Addition of Biotechnology Veteran William BaumBy Nasdaq OMXJan 16, 2018, 11:53 PM UTC
BusinessSV Health Investors Announces Promotions Within Financial TeamBy Nasdaq OMXJan 16, 2018, 4:21 PM UTC
BusinessArbutus Announces Closing of the Second Tranche of a $116M Strategic Investment from Roivant SciencesBy Nasdaq OMXJan 16, 2018, 1:30 PM UTC
BusinessMyriad Receives FDA Approval of BRACAnalysis CDx® as Companion Diagnostic for Lynparza™ (olaparib) In Patients with Metastatic Breast CancerBy Nasdaq OMXJan 12, 2018, 4:16 PM UTC
BusinessAquaBounty Technologies, Inc. Announces $12 Million Underwritten Public OfferingBy Nasdaq OMXJan 12, 2018, 2:20 PM UTC
BusinessPredictive Technology Group (PRED) Appoints John C. Nelson, M.D., M.P.H. to the Predictive Technology Group Scientific Advisory BoardBy Nasdaq OMXJan 11, 2018, 2:30 PM UTC
